Safracin B is an novel antibiotic compound produced by Pseudomonas fluorescens. Safracin B showed antitumor activity against L1210 and P388 leukemias and B16 melanoma.Early research indicates that the alpha-carbinolamine structure may plays an important role in the antitumor action of this type of antibiotic.
Download resources about recombinant antibody development and antibody engineering to boost your research.
There are currently no Customer reviews or questions for ADCsR-230CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.